Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
19.71
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
19.40
-0.31 (-1.57%)
After-hours: May 3, 2024, 5:18 PM EDT
Akero Therapeutics Employees
Akero Therapeutics had 56 employees on December 31, 2023. The number of employees increased by 18 or 47.37% compared to the previous year.
Employees
56
Change (1Y)
18
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$2,709,982
Market Cap
1.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56 | 18 | 47.37% |
Dec 31, 2022 | 38 | 4 | 11.76% |
Dec 31, 2021 | 34 | 12 | 54.55% |
Dec 31, 2020 | 22 | 8 | 57.14% |
Dec 31, 2019 | 14 | 4 | 40.00% |
Dec 31, 2018 | 10 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
Omnicell | 3,650 |
Gyre Therapeutics | 593 |
Ironwood Pharmaceuticals | 267 |
4D Molecular Therapeutics | 147 |
Ligand Pharmaceuticals | 58 |
AKRO News
- 2 days ago - AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO - PRNewsWire
- 2 days ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors - Business Wire
- 3 days ago - Akero Therapeutics, Inc. (AKRO) Investor Notice: Robbins LLP Reminds Stockholders of the Akero Therapeutics, Inc. Class Action - Business Wire
- 3 days ago - INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors - Business Wire
- 3 days ago - AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - Business Wire
- 3 days ago - The Law Offices of Frank R. Cruz Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors - Business Wire
- 3 days ago - Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc. - PRNewsWire
- 4 days ago - AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - PRNewsWire